EP1980255A1 — Pharmaceutical compositions containing synthetic steroid derivatives such as tibolone, minerals such as calcium and the active metabolite of vitamin d (calcitrol) for the prevention and treatment of osteoporosis and menopause
Assigned to World Trade Import Export Wtie AG · Expires 2008-10-15 · 18y expired
What this patent protects
The present invention generally relates to pharmaceutical industry and, in particular, to drug preparer pharmaceutical industry for controlling osteoporosis. More specifically, the present invention relates to a combination comprising a combination of a synthetic steroid derivati…
USPTO Abstract
The present invention generally relates to pharmaceutical industry and, in particular, to drug preparer pharmaceutical industry for controlling osteoporosis. More specifically, the present invention relates to a combination comprising a combination of a synthetic steroid derivative such as Tibolone, minerals such as calcium and the active metabolite of vitamin D 1,25(OH) 2 (calcitrol) for the prevention and treatment of osteoporosis. The inventive composition is advantageous over the prior art in that the same results can be obtained with a smaller amount of each of the components than when they are consumed separately or better results can be obtained with the same amount of each of the components than when they are consumed separately. Said composition consists of: a synergistic combination of a synthetic steroid, minerals and the active metabolite of vitamin D, 1,25 (OH)2 D3 (calcitrol) for the prevention and treatment of osteoporosis.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.